Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Clarivate ( (CLVT) ) has shared an announcement.
On February 24, 2026, Clarivate reported fourth-quarter and full-year 2025 results showing lower reported revenue due to divestitures but improving quality of earnings, with organic ACV up 1.8%, recurring organic revenue growing and the mix of recurring revenue rising to 88% of total. Net loss narrowed sharply in 2025 to $201.1 million from $636.7 million a year earlier, supported by stronger free cash flow of $365.3 million and $225 million of share buybacks, as management highlighted progress on its Value Creation Plan and disciplined cost control.
The company also disclosed it is pursuing a sale of its Life Sciences & Healthcare segment and is in active talks with potential buyers, a move aimed at sharpening its focus on academia, government and intellectual property markets while using anticipated proceeds to reduce leverage. For 2026, Clarivate projected continued growth in organic ACV and recurring revenues, margin expansion and roughly 10% higher free cash flow even though reported revenue will fall following strategic divestitures, signaling an ongoing shift toward a more sustainable subscription-led model and balance sheet strengthening.
The most recent analyst rating on (CLVT) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Clarivate stock, see the CLVT Stock Forecast page.
Spark’s Take on CLVT Stock
According to Spark, TipRanks’ AI Analyst, CLVT is a Neutral.
Overall score reflects ongoing profitability headwinds and only moderate financial strength, compounded by weak technical momentum (below major moving averages with negative MACD and low RSI). The score is partially supported by improving commercial metrics (ACV and renewal rates) and shareholder-friendly capital actions, but losses and flat organic growth keep the rating constrained.
To see Spark’s full report on CLVT stock, click here.
More about Clarivate
Clarivate Plc is a leading global provider of transformative intelligence, serving customers in academia, government, intellectual property, and life sciences and healthcare. The company focuses on subscription-based data, analytics and workflow solutions, increasingly integrating proprietary and agentic AI capabilities to enhance research, innovation and IP management for its clients.
Average Trading Volume: 6,156,391
Technical Sentiment Signal: Sell
Current Market Cap: $1.18B
Learn more about CLVT stock on TipRanks’ Stock Analysis page.